Search

The thermal and mechanical properties of martensitic stainless steel 422 were evaluated for suitability as a drop-in replacement for 4140 steel in next generation heavy-duty diesel engine (HDDE) pistons. The time and temperature of the austenitization and tempering steps were studied to achieve optimum materials performance in piston applications, including the balance of thermal and mechanical properties and resistance to long-term thermal aging. Reducing the tempering temperature from 700 to 600 °C caused a substantial increase in elevated temperature strength from 25 to 600 °C, but had no significant influence on thermal conductivity, suggesting that thermal conductivity in 422 is dominated largely by composition and distribution of alloying elements and mostly independent of the sub-grain structure size and precipitate size. Compared to the current HDDE piston alloy 4140, 422 exhibits substantially higher elevated temperature strength and lower thermal conductivity, the latter which will cause 422 to operate at higher temperatures in pistons, possibly requiring a piston redesign to take advantage of the improved high temperature strength of 422. Piston material selection and alloy design strategies with potential to mitigate some of the shortcomings of martensitic stainless steels, such as 422, as drop-in replacements are discussed.

The Austrian Society of Pneumology (ASP) launched a first statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in Austria 285 people had died from this disease and vaccinations were not available. Lockdown and social distancing were the only available measures to prevent more infections and the breakdown of the health system. Meanwhile, in Austria over 13,000 patients have died in association with a SARS-CoV‑2 infection and coronavirus disease 2019 (COVID-19) was among the most common causes of death; however, SARS-CoV‑2 has been mutating all the time and currently, most patients have been affected by the delta variant where the vaccination is very effective but the omicron variant is rapidly rising and becoming predominant. Particularly in children and young adults, where the vaccination rate is low, the omicron variant is expected to spread very fast. This poses a particular threat to unvaccinated people who are at elevated risk of severe COVID-19 disease but also to people with an active vaccination. There are few publications that comprehensively addressed the special issues with SARS-CoV‑2 infection in patients with chronic lung diseases. These were the reasons for this updated statement. Pulmonologists care for many patients with an elevated risk of death in case of COVID-19 but also for patients that might be at an elevated risk of vaccination reactions or vaccination failure. In addition, lung function tests, bronchoscopy, respiratory physiotherapy and training therapy may put both patients and health professionals at an increased risk of infection. The working circles of the ASP have provided statements concerning these risks and how to avoid risks for the patients., (© 2022. The Author(s).)